Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.249
-0.002 (-0.80%)
Mar 9, 2026, 2:04 PM EDT - Market open
AKTX's stock price has decreased by -73.06% in the past year and price targets may not have had time to catch up.

Akari Therapeutics, Analyst Ratings

Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$2.53
Upside
+915.25%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Ladenburg Thalmann
Ladenburg Thalmann
Strong Buy
Initiates
$1
Strong Buy Initiates $1 +301.28% Jan 5, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$1.6
Strong Buy Reiterates $1.6 +542.05% Sep 9, 2025
Maxim Group
Maxim Group
Strong Buy
Initiates
$5
Strong Buy Initiates $5 +1,906.42% Jul 18, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$30
Strong Buy Initiates $30 +11,938.52% Dec 5, 2022
Alliance Global Partners
Alliance Global Partners
Strong Buy
Initiates
$80
Strong Buy Initiates $80 +32,002.73% Nov 1, 2022
B. Riley Securities
B. Riley Securities
Strong Buy
Maintains
$140$100
Strong Buy Maintains $140$100 +40,028.41% Mar 13, 2020
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$300$160
Strong Buy Maintains $300$160 +64,105.46% Mar 29, 2018
B. Riley Securities
B. Riley Securities
Hold
Initiates
$60
Hold Initiates $60 +23,977.05% Feb 8, 2018
William Blair
William Blair
Buy
Upgrades
n/a
Buy Upgrades n/a n/a Sep 22, 2017
Chardan Capital
Chardan Capital
Hold
Upgrades
n/a
Hold Upgrades n/a n/a May 31, 2017
William Blair
William Blair
Hold
Downgrades
n/a
Hold Downgrades n/a n/a May 12, 2017
Chardan Capital
Chardan Capital
Strong Sell
Reiterates
$100$130
Strong Sell Reiterates $100$130 +52,066.93% Apr 17, 2017
Chardan Capital
Chardan Capital
Strong Sell
Initiates
$100
Strong Sell Initiates $100 +40,028.41% Jul 11, 2016